NU Form 144: 6,000 Restricted Shares to be Sold via Morgan Stanley
Rhea-AI Filing Summary
Nu Holdings Ltd. (NU) Form 144 shows an insider sale notice for 6,000 common shares to be sold via Morgan Stanley Smith Barney LLC on 08/25/2025 with an aggregate market value of $84,000. The filing reports the shares were acquired on 07/01/2024 through restricted stock vesting as compensation.
The filer also reported a prior sale of 4,000 shares on 08/15/2025 generating $55,020. The notice includes the seller name Suzana Kubric and identifies the exchange as NYSE. The form contains the required representation that the signer is not aware of undisclosed material adverse information.
Positive
- Required Rule 144 disclosures made, including broker, acquisition details, and seller identity
- Shares acquired via restricted stock vesting, indicating compensation-related liquidity rather than external divestiture
- Sale routed through a major broker (Morgan Stanley Smith Barney LLC), suggesting standard execution procedures
Negative
- None.
Insights
TL;DR: Routine insider sale of a very small number of shares from restricted stock vesting; negligible market impact.
The filing documents sale of 6,000 common shares valued at $84,000, representing an immaterial fraction of the reported 3,768,057,942 shares outstanding. Acquisition was via restricted stock vesting on 07/01/2024 and sale is routed through a major broker, indicating standard liquidity of vested awards rather than a company financing or major disposition. Prior sale of 4,000 shares on 08/15/2025 is disclosed, consistent with ongoing personal liquidity events. Overall, this is a routine disclosure with no evident material financial implications for NU.
TL;DR: Form 144 appears complete for an ordinary insider sale and includes required statements; no compliance red flags in the notice itself.
The form lists broker details, acquisition method (restricted stock vesting), payment characterization (compensation), and the seller identity, meeting typical Rule 144 disclosure elements. The signer affirms lack of undisclosed material adverse information, and a recent sale within the past month is reported. Absent additional context from the issuer, the filing shows adherence to disclosure obligations rather than governance concerns.